Table 1.
CluSO | Gene | Name | “Non-treated” group (n = 13) | Virus infected group (n = 2) | Inflammation group (n = 3) | Autoimmune group (n = 14) | ||||
---|---|---|---|---|---|---|---|---|---|---|
Regulation | logFCa | Regulation | logFCa | Regulation | logFCa | Regulation | logFCa | |||
B0717 | ANKRD10 | Ankyrin repeat domain protein 10 | Up | 2.21 (4) | nsb | nsb | nsb | |||
B0384 | ADD2 | Beta- adducin | Up | 2.12 (3) | nsb | nsb | nsb | |||
BA289 | SLC8A1 | Sodium/calcium exchanger 1 precursor | Up | 3.11 (3)* | nsb | nsb | Down | −1.24 (1) | ||
B9374 | MALAT1 | Metastasis associated lung adenocarcinoma transcript 1 protein | Down | −1.92 (3)* | nsb | nsb | Down | −1.66 (2) | ||
B1814 | C1ORF228 | Uncharacterized protein C1ORF228 | Up | 1.28 (3) | Down | −1.27 (1) | nsb | Up | 1.66 (1) | |
BF644 | SSTR2 | Somatostatin receptor type 2 | Down | −2.32 (3) | nsb | nsb | nsb | |||
B5523 | F5 | Coagulation factor V precursor | Down | −1.4 (3)* | nsb | nsb | nsb | |||
B3266 | CNTNAP2 | Contactin- associated protein-like 2 precursor | Down | −3.21 (3)* | Down | −1.25 (1) | Down | −1.08 (1) | Up | 2.03 (1) |
BG121 | TAF9B | Transcription initiation factor TFIID subunit 9B | Up | 1.91 (3) | nsb | nsb | nsb | |||
B9009 | LPP | Lipoma preferred partner | Up | 1.48 (3)* | Down | −1.64 (1) | nsb | nsb | ||
BB904 | PAWR | Prostate apoptosis response protein PAR-4 | Down | −2.09 (3) | nsb | nsb | nsb | |||
BD727 | RIF1 | Telomere-associated protein RIF1 | Down | −1.64 (3) | nsb | nsb | Up | 1.38 (1) | ||
BA240 | PDE4DIP | Myomegalin | Up | 1.27 (3) | nsb | Up | 1.11 (1) | nsb | ||
BF121 | SMAD4 | Mothers against decapentaplegic homolog 4 | Up | 1.56 (3) | nsb | nsb | Up | 1.2 (1) | ||
BJ537 | DKK3 | Dickkopf-related protein 3 | Up | 1.86 (3) | nsb | nsb | nsb | |||
B9548 | MDM4 | MDM4 P53 binding protein homolog | Up | 1.58 (3)* | nsb | nsb | nsb |
*Molecules found to also be regulated in the opposite direction, shown in a single dataset; aNumber in brackets denote the number of significant occurrences in all samples; bNon-significant.